We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$628M
AUM Growth
-$105M
Cap. Flow
-$132M
Cap. Flow %
-21%
Top 10 Hldgs %
31.66%
Holding
141
New
23
Increased
28
Reduced
42
Closed
26

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$23.5M
2
NVMI
Nova
NVMI
+$11.1M
3
APLS
Apellis Pharmaceuticals
APLS
+$7.99M
4
VKTX icon
Viking Therapeutics
VKTX
+$7.81M
5
CHKP icon
Check Point Software Technologies
CHKP
+$7.36M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$28.3M
2
CYTK icon
Cytokinetics
CYTK
+$8.91M
3
CRM icon
Salesforce
CRM
+$8.64M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$7.08M
5
ASML icon
ASML
ASML
+$6.31M

Sector Composition

Rank Sector Weight
1 Healthcare 70%
2 Technology 19.18%
3 Consumer Discretionary 3.53%
4 Communication Services 2.96%
5 Utilities 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASML icon
76
ASML
ASML
$626B
$2.37M 0.38%
2,840
-7,061
-71% -$6.31M
PRAX icon
77
CALL
Praxis Precision Medicines
PRAX
$8.58B
$2.3M 0.37%
40,000
-35,000
-47% -$1.89M
OTLK icon
78
Outlook Therapeutics
OTLK
$183M
$2.21M 0.35%
413,545
-157,883
-28% -$1.16M
VTYX
79
DELISTED
Ventyx Biosciences
VTYX
$2.21M 0.35%
1,012,749
– –
KLAC icon
80
KLA
KLAC
$239B
$2.15M 0.34%
27,750
-5,250
-16% -$412K
SHLT
81
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
$2.13M 0.34%
632,456
– –
DYN icon
82
Dyne Therapeutics
DYN
$4.7B
$2.03M 0.32%
+56,504
New +$2.25M
VRDN icon
83
Viridian Therapeutics
VRDN
$2.09B
$1.96M 0.31%
+86,094
New +$1.41M
NTR icon
84
Nutrien
NTR
$33.2B
$1.96M 0.31%
40,730
– –
ALNY icon
85
Alnylam Pharmaceuticals
ALNY
$27.5B
$1.93M 0.31%
+7,000
New +$1.82M
CMMB
86
Chemomab Therapeutics
CMMB
$11.4M
$1.91M 0.3%
+303,644
New +$1.7M
PERI icon
87
Perion Network
PERI
$375M
$1.85M 0.29%
234,609
– –
WDAY icon
88
Workday
WDAY
$39.6B
$1.83M 0.29%
+7,500
New +$1.77M
KZR
89
DELISTED
Kezar Life Sciences
KZR
$1.59M 0.25%
20,517
-184,651
-90% -$1.11M
ADI icon
90
Analog Devices
ADI
$179B
$1.53M 0.24%
6,660
-6,340
-49% -$1.43M
ATXS
91
DELISTED
Astria Therapeutics
ATXS
$1.5M 0.24%
136,582
-26,260
-16% -$292K
SRRK icon
92
Scholar Rock
SRRK
$5.67B
$1.34M 0.21%
+166,866
New +$1.47M
ALMS
93
Alumis Inc
ALMS
$3.6B
$1.33M 0.21%
125,000
– –
HOWL icon
94
Werewolf Therapeutics
HOWL
$17.2M
$1.33M 0.21%
626,810
– –
QCOM icon
95
Qualcomm
QCOM
$155B
$1.33M 0.21%
7,800
-11,025
-59% -$1.95M
ORIC icon
96
Oric Pharmaceuticals
ORIC
$1.15B
$1.32M 0.21%
+128,396
New +$1.27M
KYTX icon
97
Kyverna Therapeutics
KYTX
$444M
$1.22M 0.19%
248,651
+12,622
+5% +$97.3K
JSPR icon
98
CALL
Jasper Therapeutics
JSPR
$21M
$1.15M 0.18%
+61,100
New +$1.22M
CAPR icon
99
Capricor Therapeutics
CAPR
$223M
$938K 0.15%
+61,698
New +$305K
CLYM
100
Climb Bio
CLYM
$681M
$926K 0.15%
181,970
-33,209
-15% -$235K
2 3
4
5 6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2024 Portfolio in Review

As of Q3 2024, Sphera Funds Management held 141 positions worth $628M, down 14% from $733M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Sphera Funds Management withdrew a net $132M in Q3 2024, closing 26 positions and reducing 42 holdings. Its most notable exit was Salesforce, an estimated $8.64M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 59% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Nova worth $10.8M.

  • Sphera Funds Management's largest Q3 2024 buy was Nova: 51,960 shares worth $10.8M.
  • Sphera Funds Management added most to Teva Pharmaceuticals in Q3 2024, an estimated $23.5M increase.
  • Sphera Funds Management's biggest Q3 2024 reduction was Broadcom, cutting an estimated $28.3M.
  • Sphera Funds Management fully exited Salesforce in Q3 2024, selling an estimated $8.64M.
  • Sphera Funds Management's ten largest holdings make up 32% of its $628M portfolio in Q3 2024.
  • Sphera Funds Management opened 23 new positions and closed 26 in Q3 2024.
  • Sphera Funds Management's portfolio value fell 14% quarter-over-quarter to $628M.

Based on Sphera Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.